Biosearch S.A.
Granada, 18004, Spain
NCT Number: NCT01909661
The objective of this double blinded randomized study is to assess the tolerance of two extensively protein hydrolyzed infant formulas, one based on rice protein and the other one on casein, at introduction, and after 3 months of consumption, and their efficacy on growth and on the reduction of allergy symptoms through a 3 months consumption period.
Looking for future studies?
Notify MeUp to 9 month
All sexes
Interventional
Phase 2
Granada, 18004, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24h
Tolerance is absence of clinical signs.
Time frame: 3 months
Evaluate during 3 months of consumption the effectiveness of the formulas, in terms of :
Time frame: 3 months
Volume of infant formula consumed by the infants in 3 months
Lactalis
Industry
Tolerancia a 2 fórmulas de Leche Infantil Altamente Hidrolizadas en Base a proteínas de Arroz y a caseína en niños Con Alergia a Las proteínas de Leche de Vaca
Acronym: JUNGLO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07239856
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bobigny, France
View Trial DetailsNCT01603368
Body Weight, Digestive System Diseases
Norrköping, Sweden
View Trial DetailsNCT04226586
Bone Diseases, Bone Diseases, Developmental
Little Rock, Arkansas, United States
View Trial DetailsNCT06497907
Digestive System Diseases, Enteropathy
Cairo, Abbasia, Egypt
View Trial Details